Altana Wealth, the credit, currency and special situations-focused hedge fund led by former Trafalgar Asset Managers co-founder Lee Robinson, is circling the restructuring and consolidation opportunities arising from the rebound in demand for oil and gas post-Covid.
Established in 1984, multi-strategy alternative investment manager and opportunistic credit investor Corbin Capital Partners today manages more than USD9 billion in assets across a broad range of commingled and bespoke portfolios.
Currency-focused investment manager Millennium Global Investments has launched a new systematic long/short currency hedge fund strategy to tap into burgeoning demand for non-correlated returns in what it calls a “favourable” investment environment.
By Don Steinbrugge (pictured), Agecroft Partners – The next 15 months will be the greatest asset raising environment in the history of the hedge fund industry and potentially a once-in-a-career opportunity for managers to grow assets. The strength of asset flows to managers will be much stronger than many industry professionals expect and potentially surpass USD1 trillion.
The fallout from the Covid-19 pandemic continues to reshape the global macroeconomic and geopolitical landscape, driving both uncertainty as well as opportunity for macro managers – and the Best Macro Hedge Fund category at this year’s Hedgeweek Americas Awards will honour those managers who have successfully steered their strategies through the assortment of rapidly-evolving macro trends.
“Dig deeper”: Why Syz Capital is looking beyond hedge funds and private equity in hunt for uncorrelated returns
Investors must look beyond hedge funds and private equity in their quest for uncorrelated returns, according to Marc Syz (pictured), co-founder and managing partner at Syz Capital, who believes niche assets – such as litigation finance and life settlements – can offer investors improved portfolio diversification.
Allocators are blurring the boundaries between the hedge fund and private equity sides of their portfolios, as once strictly segmented alternatives buckets begin to blend, according to investment firm Cambridge Associates.
Los Angeles-based TrueRisk Capital is a newly-established fully-systematic CTA manager which trades a range of algorithm-based options and futures strategies developed by co-founder and chief quant Rito Bhattacharyya over the course of almost nine years.
As global economies remain finely balanced between reopening and containing Covid-19 variants, metals and mining-focused hedge fund Delbrook Capital is positioning its portfolio for fresh market volatility up ahead.
Launched in the immediate aftermath of the Global Financial Crisis, pioneering credit-focused hedge fund manager Sancus Capital Management has built a formidable decade-plus track record in the market, and more recently broadened its focus into CLO management.
The “fluidity” of virtual conferencing has proved a “silver lining” during the pandemic, optimising allocator time during the investor due diligence process, according to new research by alternatives-focused software-as-a-service and data management company Vidrio Financial.
Non-profits in the US are allocating more to hedge funds, yet private markets remain a favourite, according to TIFF Investment Management (TIFF), an outsourced chief investment officer (OCIO) serving the non-profit sector.
With CTAs and trend-following managers maintaining their positive run this year after enduring a turbulent and unpredictable 2020, the Best CTA Hedge Fund category at this year’s Hedgeweek Americas Awards will highlight how such strategies are successfully positioning for trends as markets continue on their rollercoaster ride.
By Juan Cruz (pictured), Founding Partner and CIO, Cygnus Asset Management – On the path towards a net zero emissions world, some sectors will multiply their activity (multiples), others will reduce it substantially (fractions), and others will disappear (zeros). How can hedge funds and other asset managers navigate the emerging investment opportunities?
With hedge funds’ year-to-date returns rebounding back into double-digit territory, new industry data published on Monday shows how emerging markets managers are helping to galvanise the industry and fuel recent gains.
CTAs and trend-following hedge fund strategies have experienced a sluggish start to September, having had a disappointing August in what Société Générale describes as a “challenging environment” for the sector.
London-based crypto hedge fund Nickel Digital Asset Management has seen its assets soar some 260 per cent this year, as its range of cryptocurrency-focused strategies have generated gains throughout the sector’s rollercoaster ride.
Hedge fund confidence at highest level “in many years” as industry enjoys renaissance among investors
Hedge funds are in a buoyant mood heading into the second half of the year, boosted by impressive Q2 performances and increased capital inflows, according to a key industry confidence metric.
Special situations hedge fund Sand Grove Capital has appointed banking veteran Daniel Caplan as CEO, as the firm looks to capitalise on soaring volumes of mergers and acquisitions and other corporate activity.
Trend-following hedge funds and CTA strategies have dipped slightly in recent days after ending the first half of the year in positive territory, Société Générale’s CTA indices show, but the sector is well-placed to capitalise on commodities and equities trends going forward.
Trident Trust entered the cryptocurrency sector in early 2017 as bitcoin was beginning to appreciate in value, and since then the global fund administrator – which services more than 500 funds globally, with AUM exceeding USD40 billion – has steadily carved out a burgeoning presence in the rapidly-growing digital assets sector, and now counts around 45 crypto funds among its clients.
Healthcare hedge fund Rhenman rises 12 per cent this year, as biotech and pharma bets drive June returns
Healthcare-focused equity hedge fund Rhenman & Partners scored a near-12 per cent return in the first six months of the year, as a number of correct calls in biotechnology and pharmaceuticals stocks drove gains in June.